��������

Wilhelm Stahl, Ph.D., brings 30 years of R&D, and manufacturing experience in small and large pharmaceutical and chemical manufacturing companies. Until November 2022 he served as an EVP and Chief Technology Officer of Tricida, Inc. From 2011 to 2017 he was a Senior Vice President of Pharmaceutical Operations and as Chief Technology Officer, at Relypsa, Inc. Since 2009, he has been a Managing Partner of Rondaxe Enterprises, LLC, a consulting firm, providing CMC consulting services. From 2005 to 2008, he was Head of the Pharma Custom Manufacturing business of Saltigo GmbH. Before entering into manufacturing, he has spent 14 years in different roles in pharmaceutical R&D at Bayer and companies that are today part of Sanofi.

He received a Ph.D. in Chemistry from the Institute for Organic Chemistry and Biochemistry at the University of Bonn, Germany.